Nureca Limited IPO Detail
Incorporated in 2016, Nureca Limited is a healthcare and wellness products distributor. The company aims to offer the best quality, durable, and innovative tools to customers to monitor chronic diseases to improve their lifestyle.
The firm has a well-diversified product portfolio including Chronic Device Products, Orthopedic products, Mother and Child products, Nutrition Supplements, and Lifestyle products to meet the Indian healthcare market requirements. It is the first digital company to sell such products through its website drtust.in and other online partners i.e. e-commerce players, retailers, and distributors.
- Diversified product portfolio.
- Experienced promoter and management team.
- Strong online distribution network.
- Premium quality healthcare and wellness products.
Company PromotersSaurabh Goyal is the promoter of the company.
|IPO Opening Date||Feb 15, 2021|
|IPO Closing Date||Feb 17, 2021|
|Issue Type||Book Built Issue IPO|
|Face Value||₹10 per equity share|
|IPO Price||₹396 - 400 per equity share|
|Market Lot||35 Shares|
|Min Order Quantity||35 Shares|
|Listing At||BSE, NSE|
|Issue Size||₹100 Cr|
|Fresh Issue||Eq Shares of ₹10 (aggregating up to ₹100.00 Cr)|
|Offer for Sale||-|
IPO Tentative Timetable
The Nureca Limited IPO open date is Feb 15, 2021, and the close date is Feb 17, 2021. The issue may list on Feb 25, 2021.
|IPO Open Date||Feb 15, 2021|
|IPO Close Date||Feb 17, 2021|
|Basis of Allotment Date||Feb 23, 2021|
|Initiation of Refunds||Feb 24, 2021|
|Credit of Shares to Demat Account||Feb 24, 2021|
|IPO Listing Date||Feb 25, 2021|
IPO Lot Size
The Nureca Limited IPO market lot size is 35 shares. A retail-individual investor can apply for up to 14 lots (490 shares or ₹196000).
IPO Promoter Holding
|Pre Issue Share Holding||93.33%|
|Post Issue Share Holding||70%|
For the year/period ended (₹ in Crs)
|Financial Year||Total Assets||Total Revenue||Profit After Tax|
Objects of the Issue:
The IPO proceed will be utilized towards following purposes:
- To meet the working capital requirements of the business.
- To meet general corporate purposes.